Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to lead the case, with claims asserted under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections" while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant financial losses for investors during the specified class period [1][3][4]. Group 1: Allegations and Financial Impact - The lawsuit claims that Ardent Health did not accurately assess the collectability of accounts receivable, which allowed the company to report inflated financial figures [3]. - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised assessments of accounts receivable collectability, resulting from a transition to a new revenue accounting system [4]. - The company also reduced its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $615 million to $530 million - $555 million, citing persistent industry-wide cost pressures [4]. Group 2: Professional Liability Concerns - The lawsuit alleges that Ardent Health did not maintain sufficient professional malpractice liability insurance and that its reserves were inadequate to cover increasing claims due to social inflationary pressures in the medical malpractice sector [3]. - A $54 million increase in professional liability reserves was recorded, attributed to recent settlements and ongoing litigation in New Mexico, reflecting broader industry trends [4]. Group 3: Legal Process and Representation - Investors who purchased Ardent Health securities during the class period can seek appointment as lead plaintiff in the class action lawsuit, which allows them to represent the interests of all class members [5]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect an investor's ability to share in any potential recovery [5]. Group 4: Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has a strong track record in obtaining significant recoveries in securities class action cases, including the largest recovery in history at $7.2 billion in the Enron case [6].

NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ar ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health operates acute care hospitals and healthcare facilities, with a focus on the collection of accounts receivable [4]. - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections," while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health announced a $43 million decrease in revenue for the quarter and a $54 million increase in professional liability reserves due to adverse claims developments [5]. - Following this announcement, Ardent Health's stock price dropped by $4.75 per share, or over 33%, from $14.05 to $9.30 per share [5].

Core Viewpoint - Hagens Berman is investigating Ardent Health, Inc. for allegedly misleading investors regarding its revenue recognition systems and professional liability reserves, leading to significant financial repercussions and a class action lawsuit [2][4]. Group 1: Allegations and Financial Impact - Ardent Health reportedly assured investors of using "detailed reviews of historical collections" for valuing receivables, but later admitted to employing a "180-day cliff" for reserves, which contributed to a 33% stock collapse [2][5]. - The company experienced a $54 million increase in professional liability reserves due to settlements and ongoing litigation, alongside a $42.6 million revenue reduction attributed to a new accounting method for estimating receivables [5]. - Following the disclosures on November 12, 2025, Ardent's stock price fell nearly 34%, indicating a severe market reaction to the revelations [5]. Group 2: Legal Proceedings and Next Steps - A lead plaintiff deadline for the pending securities class action is set for March 9, 2026, with Hagens Berman actively advising investors who purchased shares between July 18, 2024, and November 12, 2025 [4][5]. - The lawsuit claims that Ardent's financial health was misrepresented, suggesting that the company's monitoring of receivables was a facade for a mechanical write-off system [3][4].

LOS ANGELES, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ardent Health, Inc., (“Ardent” or the "Company") (NYSE: ARDT) investors off a class action on behalf of investors that bought securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). Ardent investors have until March 9, 2026 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal right ...

SAN DIEGO, Jan. 29, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the "Class Period"), have until March 9, 2026 to seek appointment as lead plaintiff of the Ardent Health class action lawsuit. Captioned Postiwala v. Ardent Health, Inc., No. 26-cv-00022 (M.D. Tenn.), the Ardent Health class action lawsuit charges Ardent Health as well as certain of Ardent Healt ...

NEW YORK, Jan. 29, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ardent Health, Inc. (NYSE: ARDT). Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183282&from=4 CLASS PERIOD: July 18, 202 ...

Core Viewpoint - A securities class action lawsuit has been filed against Ardent Health, Inc. following its poor Q3 2025 financial results, alleging misleading statements regarding revenue recognition and liability reserves [1][2]. Company Allegations - The lawsuit claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves, urging affected investors to come forward [2][4]. - The complaint states that Ardent assured investors of an active monitoring process for accounts receivable, which was misleading as the company primarily used a 180-day cliff for reserving accounts [4][5]. Financial Impact - On November 12, 2025, Ardent disclosed a transition to a new accounting method that resulted in a revenue reduction of $42.6 million due to hindsight evaluations [5][6]. - The company's CFO indicated that the new accounting system recognized reserves earlier in an account's life cycle, contrasting previous assurances [6]. - Additionally, Ardent reported a $47.2 million increase in professional liability reserves, contributing to a rise in total operating expenses as a percentage of total revenue [6]. Market Reaction - Following the announcement of the financial results and the new accounting method, Ardent's share price fell by $4.75, a decrease of 33% [6]. Investigation and Whistleblower Information - Hagens Berman is investigating whether Ardent was aware of issues with its revenue accounting system that concealed payor denials [7]. - Whistleblowers with non-public information regarding Ardent Health are encouraged to assist in the investigation, with potential rewards under the SEC Whistleblower program [8].

NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Ardent Health, Inc. (NYSE: ARDT). Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183252&from=3 CLASS PERIOD: July 18, ...